DIFFERENT MODES OF POTENTIATION BY BETA-EUDESMOL, A MAIN COMPOUND FROM ATRACTYLODES-LANCEA, DEPENDING ON NEUROMUSCULAR BLOCKING ACTIONS OF PARA-PHENYLENE-POLYMETHYLENE BIS-AMMONIUM DERIVATIVES IN ISOLATED PHRENIC NERVE-DIAPHRAGM MUSCLES OF NORMAL AND ALLOXAN-DIABETIC MICE

被引:4
作者
KIMURA, M [1 ]
KIMURA, I [1 ]
MUROI, M [1 ]
TANAKA, K [1 ]
NOJIMA, H [1 ]
UWANO, T [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,SUGITANI,TOYAMA 93001,JAPAN
关键词
BETA-EUDESMOL; PARA-PHENYLENE-POLYMETHYLENE BIS-AMMONIUM; DIABETIC MICE; NEUROMUSCULAR BLOCKADE;
D O I
10.1254/jjp.60.19
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The essential moieties in p-phenylene-polymethylene bis-ammonium (PMBA) derivatives, C6H4[X(CH2)(n)N+R3]2, on the potentiating effects by beta-eudesmol, a main component of Atractylodes lancea, of their neuromuscular blockades were investigated in isolated phrenic nerve-diaphragm muscle preparations of normal and alloxan-diabetic mice. PMBA derivatives were separated into the following three groups based on the patterns of the potentiating effects: group I: PMBA-23 (n = 6, R = Me) and PMBA-24 (n = 6, R = Et); group 11: PMBA-1 (n = 4, R = Me), PMBA-21 (n = 4, R = Et) and PMBA-2 (X = O, n = 3, R = Me); and group III: PMBA-31 (X = S, n = 3, R = Me), PMBA-3 (X = CO, n = 3, R = Me) and PMBA-4 (X = CHOH, n = 3, R = Me). The pretreatment with 80 muM beta-eudesmol for 60 min did not affect group I-induced neuromuscular blocking action, and it potentiated group II- and group III-induced ones. The potentiating effect of beta-eudesmol on group III was greater in diabetic muscles than in normal ones and that on group II was to the same extent in both muscles. These results suggest that the four-methylene length of the side chains in normal muscles and the hydrophilic moieties adjacent to a phenylene ring in diabetic muscles are related to the potentiating effect by beta-eudesmol on PMBA derivatives.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 10 条
[2]
DIABETES MELLITUS-INDUCED HYPERSENSITIVITY OF MOUSE SKELETAL-MUSCLES TO ACETYLCHOLINE AND SUCCINYLCHOLINE [J].
KIMURA, M ;
KIMURA, I ;
NOJIMA, H ;
MUROI, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 (02) :251-256
[3]
MECHANISM OF THE BLOCKING ACTION OF BETA-EUDESMOL ON THE NICOTINIC ACETYLCHOLINE-RECEPTOR CHANNEL IN MOUSE SKELETAL-MUSCLES [J].
KIMURA, M ;
NOJIMA, H ;
MUROI, M ;
KIMURA, I .
NEUROPHARMACOLOGY, 1991, 30 (08) :835-841
[4]
A STUDY IN VITRO OF NEW SHORT-ACTING NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS [J].
KITZ, RJ ;
KARIS, JH ;
GINSBURG, S .
BIOCHEMICAL PHARMACOLOGY, 1969, 18 (04) :871-&
[5]
INCREASE IN THE ACTIVITIES OF PLASMA PSEUDOCHOLINESTERASE DEPENDENT ON THE BLOOD-GLUCOSE LEVEL AND ITS RELATION TO THE HYPERSENSITIVITY TO ACETYLCHOLINE IN STRIATED MUSCLES OF KK-CAY MICE WITH DIABETES [J].
MATSUI, T ;
KIMURA, I ;
KIMURA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 54 (02) :97-103
[6]
MINKER E, 1986, ACTA PHYSIOL HUNG, V67, P257
[7]
BETA-EUDESMOL (A MAIN COMPONENT OF ATRACTYLODES-LANCEA) INDUCED POTENTIATION OF DEPOLARIZING NEUROMUSCULAR BLOCKADE IN DIAPHRAGM MUSCLES OF NORMAL AND DIABETIC MICE [J].
MUROI, M ;
TANAKA, K ;
KIMURA, I ;
KIMURA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 50 (01) :69-71
[8]
NOJIMA H, IN PRESS J PHARM PHA
[9]
SCHOFIELD GG, 1978, ACTA DIABETOL LAT, V15, P287, DOI 10.1007/BF02590752
[10]
THESLEFF S, 1954, J PHARMACOL EXP THER, V111, P99